References
- Yaseen H, Khalaf M, Rashid N, Darwich M. Does prophylactic phototherapy prevent hyperbilirubinemia in neonates with ABO incompatibility and Positive Coombs’ Test? J Perinatology 2005;25:590–4
- Dufour DR, Monoghan WP. ABO hemolytic disease of the newborn. A retrospective analysis of 254 cases. Am J Clin Pathol 1980;73:369–73
- Subcommittee on Hyperbilirubinemia, American Academy of Pediatrics Clinical Practice Guideline. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316
- Madan A, Huntsinger K, Burgos A, Benitz WE. Readmission for newborn jaundice: the value of the Coombs’ test in predicting the need for phototherapy. Clin Pediatr 2004;43:63–8
- Sarici SU, Yurdakok M, Serdar MA, et al. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinaemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. Pediatrics 2002;109:53--59
- Schutzman DL, Sekhon R, Hundalani S. Hour-specific bilirubin nomogram in infants with ABO incompatibility and Direct Coombs-Positive results. Arch Pediatr Adolesc Med 2010;164:1158–64
- Dillon A, Chaudhari T, Crispin P, et al. Has anti-D prophylaxis increased the rate of positive direct antiglobulin test results and can the direct antiglobulin test predict need for phototherapy in Rh/ABO incompatibility? J Paediatr Child Health 2011;47:40–3
- Madlon-Kay DC. The clinical significance of ABO blood group incompatibility. Arch Fam Med 1993;2:285–7
- Dinesh D. Review of positive direct antiglobulin tests found on cord blood sampling. J Paediatr Child Health 2005;41:504–7